121 related articles for article (PubMed ID: 36701555)
1. Nitric Oxide-Loaded Bioinspired Lipoprotein Normalizes Tumor Vessels To Improve Intratumor Delivery and Chemotherapy of Albumin-Bound Paclitaxel Nanoparticles.
Wu Y; Xie H; Li Y; Bao X; Lu GL; Wen J; Gao Y; Li Y; Zhang Z
Nano Lett; 2023 Feb; 23(3):939-947. PubMed ID: 36701555
[TBL] [Abstract][Full Text] [Related]
2. Bioinspired lipoproteins-mediated photothermia remodels tumor stroma to improve cancer cell accessibility of second nanoparticles.
Tan T; Hu H; Wang H; Li J; Wang Z; Wang J; Wang S; Zhang Z; Li Y
Nat Commun; 2019 Jul; 10(1):3322. PubMed ID: 31346166
[TBL] [Abstract][Full Text] [Related]
3. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
[TBL] [Abstract][Full Text] [Related]
4. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
5. Heat/pH-boosted release of 5-fluorouracil and albumin-bound paclitaxel from Cu-doped layered double hydroxide nanomedicine for synergistical chemo-photo-therapy of breast cancer.
Liu J; Liu K; Zhang L; Zhong M; Hong T; Zhang R; Gao Y; Li R; Xu T; Xu ZP
J Control Release; 2021 Jul; 335():49-58. PubMed ID: 33989692
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy.
Hong C; Wang A; Xia J; Liang J; Zhu Y; Wang D; Zhan H; Feng C; Jiang X; Pan J; Wang J
Int J Nanomedicine; 2024; 19():2879-2888. PubMed ID: 38525007
[TBL] [Abstract][Full Text] [Related]
7. Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.
Tanaka S; Iwamoto M; Kimura K; Matsunami N; Morishima H; Yoshidome K; Nomura T; Morimoto T; Yamamoto D; Tsubota Y; Kobayashi T; Uchiyama K
Clin Breast Cancer; 2015 Jun; 15(3):191-6. PubMed ID: 25579459
[TBL] [Abstract][Full Text] [Related]
8. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.
Mpekris F; Papageorgis P; Polydorou C; Voutouri C; Kalli M; Pirentis AP; Stylianopoulos T
J Control Release; 2017 Sep; 261():105-112. PubMed ID: 28662901
[TBL] [Abstract][Full Text] [Related]
9. Complete regression of xenografted breast tumors by dextran-based dual drug conjugates containing paclitaxel and docosahexaenoic acid.
Wang S; Liu J; Lv H; Huang X; Dong P; Wang Q; Yang H; Wang S; Li X; Hu J; Wang D; Cao S; Xie L; Shi Y
Eur J Med Chem; 2022 Oct; 240():114567. PubMed ID: 35779290
[TBL] [Abstract][Full Text] [Related]
10. Reduction-Responsive and Multidrug Deliverable Albumin Nanoparticles: An Antitumor Drug to Abraxane against Human Pancreatic Tumor-Bearing Mice.
Hirakawa N; Ishima Y; Kinoshita R; Nakano R; Chuang VTG; Ando H; Shimizu T; Okuhira K; Maruyama T; Otagiri M; Ishida T
ACS Appl Bio Mater; 2021 May; 4(5):4302-4309. PubMed ID: 35006842
[TBL] [Abstract][Full Text] [Related]
11. Albumin-based lipoprotein nanoparticles for improved delivery and anticancer activity of curcumin for cancer treatment.
Kumari P; Paul M; Bobde Y; Soniya K; Kiran Rompicharla SV; Ghosh B; Biswas S
Nanomedicine (Lond); 2020 Dec; 15(29):2851-2869. PubMed ID: 33275041
[No Abstract] [Full Text] [Related]
12. Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy.
Qian X; Wang Y; Xie H; Wang C; Li J; Lei Y; Liu H; Wu Y; Li Y; Zhang Z
J Control Release; 2023 Jan; 353():447-461. PubMed ID: 36470332
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
[TBL] [Abstract][Full Text] [Related]
14. Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis.
Liu R; Xiao W; Hu C; Xie R; Gao H
J Control Release; 2018 May; 278():127-139. PubMed ID: 29630985
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of Pirarubicin and Paclitaxel by Human Serum Albumin Nanoparticles to Enhance Antitumor Effect and Reduce Systemic Toxicity in Breast Cancers.
Yi X; Lian X; Dong J; Wan Z; Xia C; Song X; Fu Y; Gong T; Zhang Z
Mol Pharm; 2015 Nov; 12(11):4085-98. PubMed ID: 26422373
[TBL] [Abstract][Full Text] [Related]
16. Green design "bioinspired disassembly-reassembly strategy" applied for improved tumor-targeted anticancer drug delivery.
Wang R; Gu X; Zhou J; Shen L; Yin L; Hua P; Ding Y
J Control Release; 2016 Aug; 235():134-146. PubMed ID: 27238442
[TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of therapeutic agents by using targeted albumin nanoparticles.
Kouchakzadeh H; Safavi MS; Shojaosadati SA
Adv Protein Chem Struct Biol; 2015; 98():121-43. PubMed ID: 25819278
[TBL] [Abstract][Full Text] [Related]
18. [Chinese expert consensus of albumin-bound paclitaxel in the treatment of breast cancer].
;
Zhonghua Zhong Liu Za Zhi; 2023 Mar; 45(3):203-211. PubMed ID: 36944541
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer.
Zhang W; Xu Y; Shi X; Huang X; Chen R; Xu H; Shi W; Wan X; Wang Y; He J; Li C; Wang J; Zha X
Nanomedicine (Lond); 2022 Apr; 17(10):683-694. PubMed ID: 35393861
[TBL] [Abstract][Full Text] [Related]
20. Bioinspired Lipoproteins of Furoxans-Oxaliplatin Remodel Physical Barriers in Tumor to Potentiate T-Cell Infiltration.
Wang Y; Xie H; Wu Y; Xu S; Li Y; Li J; Xu X; Wang S; Li Y; Zhang Z
Adv Mater; 2022 Apr; 34(14):e2110614. PubMed ID: 35092711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
